Phase I study of putaminal gene transfer with adeno-associated virus serotype 2 [AAV2]-neurturin [NTN] (CERE-120) for Parkinson's disease: Preliminary observations

被引:0
|
作者
Marks, WJ
Metman, LAV
Starr, PA
Larson, PS
Bakay, RA
Taylor, R
Cahn-Weiner, D
Bartus, RT
Ostrem, JL
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:A185 / A185
页数:1
相关论文
共 34 条
  • [31] Adeno-Associated Virus Type 2 Vector-Mediated Glial Cell Line-Derived Neurotrophic Factor Gene Transfer Induces Neuroprotection and Neuroregeneration in a Ubiquitin-Proteasome System Impairment Animal Model of Parkinson's Disease
    Du, Yunlan
    Zhang, Xiaojie
    Tao, Qingqing
    Chen, Sheng
    Le, Weidong
    NEURODEGENERATIVE DISEASES, 2013, 11 (03) : 113 - 128
  • [32] Danon Disease Phase 1 RP-A501 Results: The First Single-Dose Intravenous (IV) Gene Therapy with Recombinant Adeno-Associated Virus (AAV9:LAMP2B) for a Monogenic Cardiomyopathy
    Greenberg, Barry
    Rossano, Joseph
    Taylor, Matthew
    Adler, Eric D.
    Lin, Kimberly Y.
    Eshraghian, Emily
    Attias, Jennifer
    Hong, Kimberly N.
    Urey, Marcus Anthony
    Shah, Monica
    Ricks, David
    Yarabe, Paul
    Schwartz, Jonathan
    MOLECULAR THERAPY, 2023, 31 (04) : 6 - 6
  • [33] Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pathology (July, 10.1038/s41380-022-01693-6, 2022)
    Yang, Yunseon
    Seok, Min-Jong
    Kim, Ye Eun
    Choi, Yunjung
    Song, Jae-Jin
    Sulistio, Yanuar Alan
    Kim, Seong-hoon
    Chang, Mi-Yoon
    Oh, Soo-Jin
    Nam, Min-Ho
    Kim, Yun Kyung
    Kim, Tae-Gyun
    Im, Heh-In
    Koh, Seong-Ho
    Lee, Sang-Hun
    MOLECULAR PSYCHIATRY, 2023, 28 (12) : 5378 - 5379
  • [34] Preliminary Efficacy of Bilateral Intraputaminal Delivery of GDNF Gene Therapy (AAV2-GDNF; AB-1005) in Parkinson's disease (PD): 18-Month Follow-Up From a Phase 1b Study
    Phielipp, N.
    Christine, C.
    Merola, A.
    Elder, J.
    Larson, P.
    Sebastian, W. San
    Fiandaca, M.
    Urrea, C.
    Wisniewski, M.
    Van Laar, A.
    Kells, A.
    Bankiewicz, K.
    MOVEMENT DISORDERS, 2024, 39 : S340 - S340